Document is current
Any future updates will be listed below
-
Authors
Gasteiger, Chiara https://orcid.org/0000-0002-0597-2349
Scholz, Urte https://orcid.org/0000-0003-0184-5921
Petrie, Keith J. https://orcid.org/0000-0002-6337-2480
Dalbeth, Nicola https://orcid.org/0000-0003-4632-4476
- License Information
-
More Information
Article History
Received: 8 September 2021
Accepted: 18 October 2021
First Online: 27 October 2021
Declarations
:
: Nicola Dalbeth has received speaker fees, consulting fees, or grants from Janssen and Abbvie, AstraZeneca, and Amgen. The other authors declare no conflicts of interest.
: Ethical approval was obtained from the New Zealand Health and Disability Ethics Committee (19/CEN/163) and institutional approval was obtained from Auckland District Health Board (A+8700) and Waitematā District Health Board (RM14629). Research was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all individual participants included in the study.
